JUNS Stock Analysis: Buy, Sell, or Hold?
JUNS - Jupiter Neurosciences, Inc. Common Stock
$0.17
-0.01 (-3.82%)
▼
5d:
-19.02%
30d:
-23.69%
90d:
-56.2%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 17, 2026
Get Alerted When JUNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: JUNS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: JUNS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: JUNS is currently trading at $0.17, which is considered oversold relative to its 30-day fair value range of $0.21 to $0.25. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.0) compared to its historical average (9.1). Remarkably, the market is currently pricing in an annual earnings decline of 30.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, JUNS is in a strong downtrend. The price is currently testing key support at $0.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: JUNS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+16410.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, JUNS is in a strong downtrend. The price is currently testing key support at $0.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: JUNS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+16410.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.21 -
$0.25
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 16410.7% below Wall St target ($30.00)
- CAUTION: 5-day price weakness (-19.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.21 -
$0.25
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.29
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.03
Wall Street Target
$30.00
(+16410.7%)
Valuation Discount vs History
-30.6% cheaper
PE vs Historical
3.0 vs 9.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-30.6%
(market-implied from PE analysis)
1-Year Target
$0.16
(-10%)
2-Year Target
$0.15
(-19%)
3-Year Target
$0.13
(-27%)
3-Yr Target (if PE normalizes)
(PE: 3→9)
$0.40
(+119%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.0 to 9.1
Stabilization Target:
$0.55
(+200.5%)
PE Expansion Potential:
+200.5%
Share & Embed Analysis
Last updated: July 14, 2026 11:16 AM ET
Data refreshes hourly during market hours. Next update: 12:16 PM
Data refreshes hourly during market hours. Next update: 12:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JUNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
